• Nektar Therapeutics (NASDAQ:NKTR) Given Consensus Rating of "Moderate Buy" by Brokerages

    المصدر: Buzz FX / 08 فبراير 2025 03:06:10   America/Chicago


    Nektar Therapeutics (NASDAQ:NKTR) Given Consensus Rating of "Moderate Buy" by Brokerages Written by MarketBeat February 8, 2025 Share Link copied to clipboard. Shares of Nektar Therapeutics ( NASDAQ:NKTR - Get Free Report ) have received an
    Read more...
شارك على،